Related Experiment Video
Updated: May 23, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Starfish™ heart positioner maintains right ventricular function during lateral wall displacement
Nobuki Ishikawa1, Go Watanabe, Hiroshi Ohtake
1Department of General and Cardiothoracic Surgery, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Starfish™ maintained hemodynamic stability and right ventricular function during lateral heart displacement in pigs, unlike deep pericardial sutures (DPS). This study highlights Starfish™ as a safer alternative for cardiac procedures.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Surgical Techniques
Background:
- Assessing cardiovascular function during beating heart surgery is critical.
- Deep pericardial sutures (DPS) can cause hemodynamic compromise.
- The Starfish™ device's impact on right ventricular function needs clarification.
Purpose of the Study:
- To evaluate cardiovascular parameters using Starfish™ and DPS in a porcine model.
- To determine the toleration of right ventricular function with Starfish™ during lateral wall displacement.
Main Methods:
- Eight healthy pigs underwent hemodynamic monitoring.
- Swan-Ganz thermodilution catheters quantified cardiac output (CO) and right ventricular ejection fraction (RVEF).
- Comparison between Starfish™, DPS, and baseline positions.
Main Results:
- DPS caused significant hemodynamic compromise, decreasing CO and RVEF (P < 0.05).
- Starfish™ maintained CO and RVEF, showing no significant changes (P > 0.05).
- Starfish™ demonstrated superior hemodynamic stability compared to DPS.
Conclusions:
- Starfish™ preserves right ventricular function and hemodynamic stability.
- DPS leads to significant hemodynamic compromise.
- Starfish™ is a viable option for maintaining cardiac function during lateral displacement procedures.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
